Vertaling van "blood safety and transfusion " (Nederlands → Frans) :

‐ Goodrich RP, Edrich RA, Goodrich LL, Scott CA, Manica KJ, Hlavinka DJ, et al. The Antiviral and Antibacterial Properties of Riboflavin and Light: Applications To Blood Safety and Transfusion Medicine.
and Antibacterial Properties of Riboflavin and Light: Applications To Blood Safety and Transfusion Medicine.

Meeting of the Advisory Committee on Blood Safety & Availability (ACSBA), 30 May 2008: Clinical Significance of Red Cell Age in Transfusions; 2008 [accessed 2008 June 17].
Meeting of the Advisory Committee on Blood Safety & Availability (ACBSA), 30 May 2008: Clinical Significance of Red Cell Age in Transfusions; 2008 [accessed 2008 June 17].

- de AABB Standards for Blood Banks and Transfusion Services laten het gebruik van bloed van therapeutische aderlatingen toe voor allogene transfusies (AABB, 2002);
- les Standards for Blood Banks and Transfusion Services de l’AABB autorisent l’utilisation de sang provenant de saignées thérapeutiques à des fins de transfusions allogéniques (AABB, 2002);

7.3 RESEARCH QUESTIONS IMPROVING OPTIMAL BLOOD SAFETY______________________________34
7.3 RESEARCH QUESTIONS IMPROVING OPTIMAL BLOOD SAFETY______________________________35

In de EU werd op het ‘Adare Colloquium on Blood Safety and Self-sufficiency’ in 1996 besloten dat ALT screening overbodig geworden was.
Dans l’UE, il a été décidé à l’‘Adare Colloquium on Blood Safety and Self-sufficiency’, en 1996, que le dépistage ALT était devenu superflu.

Nucleic acid sequence based amplification Nucleic Acid Amplification Testing Non-heart beating donors National Institute for Biological Standards and Control Optische densiteit Occupational Safety and Health Administration Perazijnzuur Phosphate buffered saline Polymerase chain reaction Perazijnzuur ethanol sterilisatie Positive predictive value Positief predictieve waarde Polyvinyl-pyrrolidon Povidone-iodine Quaternaire ammoniumverbindingen Radio-immunoprecipitatie test Ribonucleic acid Ribonuclease H Respiratoir syncytiaal virus Reverse transcriptase Advisory Committee on the Safety of Blood, Tissues and Organs Sterility assurance level Severe acute respiratory syndrome Median tissue culture infective dose Transcription-mediated amplification Tumor necrosis factor United Kingdom United Kingdom Blood Transfusion Services Ultraviolet Vapour-phase hydrogen peroxide Verenigde Staten Werkgroep infectiepreventie West Nile virus World Health Organization
Morbidity and mortalility weekly report Nucleic acid sequence based amplification Nucleic Acid Amplification Testing National Institute for Biological Standards and Control Occupational Safety and Health Administration Phosphate buffered saline ou tampon phosphate Polymerase chain reaction Stérilisation acide peracétique-éthanol Positive predictive value Polyvinyl-pyrrolidon Povidone-iodine Dérivés de l’ammonium quaternaire Ribonuclease H Reverse transcriptase ou transcriptase inverse Advisory Committee on the Safety of Blood, Tissues and Organs Sterility assurance level Severe acute respiratory syndrome Syndrome d’immunodéficience acquise Median tissue culture infective dose Test d’immunofluorescence indirecte Transcription-mediated amplification Tumor necrosis factor Test de radio-immunoprécipitation United Kingdom United Kingdom Blood Transfusion Services Ultraviolet Vapour-phase hydrogen peroxide Valeur prédictive positive Virus respiratoire syncytial Etats-Unis Werkgroep infectiepreventie ou groupe de travail sur la prévention des infections West Nile virus World Health Organization

Daarnaast werd PubMed uitputtend doorzocht aan de hand van de volgende sleutelworden: cardiac surgery, erythrocyte, red blood cell, transfusion, storage, storage lesion, blood banking, old blood en fresh blood.
En outre, une recherche exhaustive a été réalisée dans la banque de données PubMed à l’aide des mots clés suivants: cardiac surgery, erythrocyte, red blood cell,

In het document van de Raad van Europa “Pathogen inactivation of labile Blood products” wordt het volgende besloten:” Pathogen inactivation of labile blood products will diminish the risk of transfusion-transmitted disease and immunomodulatory disturbances.
Dans le document du Conseil de l’Europe “Pathogen inactivation of labile Blood products”, la conclusion est la suivante : ” Pathogen inactivation of labile blood products will diminish the risk of transfusion-transmitted disease and immunomodulatory disturbances.

72. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97(6):562-8.
72. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, et al. Beneficial effects of leukocyte depletion of transfused blood on

MeSH: Insurance, Liability ; Actuarial Analysis ; Malpractice, Blood Transfusion
MeSH : Insurance, Liability ; Actuarial Analysis ; Malpractice, Blood Transfusion